Mar 1, 2026 Log in

News

【Excelsior Medical】March 2026 Revenue NT$842 Million (YoY +15.1%)

Citation-Grade Primary-source linked Schema.org verified NQ 5 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated Jun 13, 2026 11:45 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Excelsior Medical's revenue for March 2026 was NT$842 million, an increase of 15.1% year-over-year.
The company operates in the Biotechnology and Medical Care industry.

Excelsior Medical's revenue for March 2026 was NT$842 million, an increase of 15.1% year-over-year. The company operates in the Biotechnology and Medical Care industry.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/revenue/twse-rev-4104-11503 Distributor: PR Times
Published: Mar 1, 2026

Company Ticker: 4104 Company Name: Excelsior Medical Industry: Biotechnology and Medical Care Data Month: 2026-03 Monthly Revenue: 841,634 thousand TWD (842 million) Year-over-Year Change: +15.1%

FACT BOX

Source: PR Times
Category: News
Dates in source: 2026-03

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　Apr 12, 2026 4:30 PM
AI structured & analyzed　Apr 12, 2026 9:27 PM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

What was Excelsior Medical's revenue in March 2026?

It was TWD 842 million, recording double-digit growth of 15.1% year-over-year.

What is Excelsior Medical's main business?

Its core business is providing dialysis services for patients with kidney disease and selling related medical equipment.

Why is Excelsior Medical's performance strong?

Its growth is supported by an increasing number of patients requiring dialysis due to an aging population, as well as business expansion in the Asian region.

Cite this article — HOW TO CITE

Washin AI News Desk“【Excelsior Medical】March 2026 Revenue NT$842 Million (YoY +15.1%)”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.idaeo.ai/ai/%E4%BD%B3%E9%86%AB/en/news/2026-04-12-news-2ixgpy

AI CRAWLER ACTIVITY

as of Aug 17, 2026

AI crawler visits to this article (cumulative)42 bots

Site-wide cumulative

Applebot

bot_visits_summary

2830k

last Aug 17, 2026

GPTBot

bot_visits_summary

2063k

last Aug 17, 2026

Bingbot

bot_visits_summary

758k

last Aug 17, 2026

ClaudeBot

bot_visits_summary

619k

last Aug 17, 2026

Amazonbot

bot_visits_summary

601k

last Aug 17, 2026

Meta AI

bot_visits_summary

478k

last Aug 17, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 佳醫 Back to newsroom (76)

Copied